Findings for diagnosis of eight common cancers during spring 2020 and winter 2020 to 2021.
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
There was no significant difference in the risk of hypersensitivity reactions with low-dose or high-dose dexamethasone.
Researchers identified 91 ACE2-lowering antineoplastic compounds.
How significant is the racial disparity in treating patients with skin cancer? Studies in recent years that suggest a troubling difference in the diagnosis and treatment some patients receive. We explore the significant impact this has on patient prognosis.